Kronos Bio Files 8-K: Acquisition, Delisting Notice, Control Change
| Field | Detail |
|---|---|
| Company | Kronos Bio, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | high |
| Sentiment | mixed |
Sentiment: mixed
Topics: acquisition, delisting, governance, corporate-action
TL;DR
Kronos Bio 8-K: Acquisition done, delisting warning, control change, exec shuffle. Big moves happening.
AI Summary
On June 20, 2025, Kronos Bio, Inc. filed an 8-K report detailing several significant events. These include the completion of an acquisition or disposition of assets, a notice of potential delisting or failure to meet listing rules, material modifications to security holder rights, and changes in control of the registrant. The filing also covers departures or appointments of officers and directors, and amendments to corporate documents.
Why It Matters
This 8-K filing indicates substantial corporate changes at Kronos Bio, potentially impacting its stock listing, asset structure, and governance, which are critical for investors to monitor.
Risk Assessment
Risk Level: high — The filing mentions a notice of delisting or failure to meet listing rules, alongside changes in control and asset dispositions, indicating significant operational and financial instability.
Key Players & Entities
- Kronos Bio, Inc. (company) — Registrant
- June 20, 2025 (date) — Date of Report
FAQ
What specific assets were involved in the acquisition or disposition?
The filing does not specify the exact assets involved in the acquisition or disposition of assets.
What are the reasons for the notice of delisting or failure to satisfy a continued listing rule?
The filing does not provide specific details regarding the reasons for the notice of delisting or failure to satisfy a continued listing rule.
What are the material modifications to the rights of security holders?
The filing indicates material modifications to the rights of security holders but does not detail the specific nature of these modifications.
What triggered the change in control of Kronos Bio, Inc.?
The filing confirms a change in control of the registrant but does not specify the event or transaction that caused it.
Are there any specific compensatory arrangements for certain officers mentioned in the filing?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item of disclosure but does not provide specific details within the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Kronos Bio, Inc..